Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.500
-0.040 (-2.60%)
At close: Jun 23, 2026, 4:00 PM EDT
1.460
-0.040 (-2.67%)
After-hours: Jun 23, 2026, 6:15 PM EDT
Pulmatrix Earnings Call Transcripts
Fiscal Year 2024
-
The merger will create a Nasdaq-listed biotech with a strong cash position, focused on advancing Cullgen's targeted protein degrader and DAC pipeline. Pulmatrix stockholders will retain a small stake and potential asset sale proceeds, while Cullgen's technology and collaborations drive future growth.